文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

[Response surface method for optimization of asiatic acid nanoparticles modified with PEG and its enhancing effects on intestinal absorption].

作者信息

Huang Xia-Ying, Zhang Ya-Wen, Yin Li-Na, Liang Ze-Hua, Zhu Liang, Wang Sheng-Hao

机构信息

Zhejiang Academy of Medical Sciences, Hangzhou 310013, China.

Department of Pharmacy, Zhejiang Chinese Medicine University, Hangzhou 310053, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2016 Sep;41(17):3239-3243. doi: 10.4268/cjcmm20161719.


DOI:10.4268/cjcmm20161719
PMID:28920376
Abstract

A solvent diffusion method was used to prepare pegylated asiatic acid (AA) loaded nanostructured lipid carriers (p-AA-NLC). Then central composite design-response surface method was used to obtain optimum condition for preparation technology of p-AA-NLC, where PEG/lipid ratio was 8.0% and AA/lipid ratio was 22.0%. Under the optimum condition, the system had particle size of (111.2±2.9) nm, Zeta potential of (-37.1±0.9) mV, drug loading of (15.4±0.2)% and entrapment efficiency greater than 90%. The deviations between observed values and predicated values were all below 5%, indicating that the established model had a good predictability. Meanwhile, a low-speed single pass perfusion model of rat in situ was set up to estimate the absorption kinetics of p-AA-NLC in small intestine, where the effective permeability (Peff), absorption rate constant (Ka) and other parameters were used to evaluate the drug absorption. It turned out that Peff and Ka in p-AA-NLC group were significantly higher than those in unmodified group (P<0.05), indicating that asiatic acid loaded nanostructured lipid carriers (AA-NLC) could enhance the effects on intestinal absorption after being modified with hydrophilic PEG.

摘要

相似文献

[1]
[Response surface method for optimization of asiatic acid nanoparticles modified with PEG and its enhancing effects on intestinal absorption].

Zhongguo Zhong Yao Za Zhi. 2016-9

[2]
[Oral absorption of asiatic acid nanoparticles modified with PEG].

Zhongguo Zhong Yao Za Zhi. 2017-7

[3]
Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects.

Drug Dev Ind Pharm. 2020-1-10

[4]
Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis.

Drug Deliv. 2021-12

[5]
Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.

Drug Deliv. 2016-11

[6]
Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.

Drug Deliv. 2016

[7]
Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine.

Pharmazie. 2012-4

[8]
Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.

Colloids Surf B Biointerfaces. 2007-11-15

[9]
Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.

Drug Dev Ind Pharm. 2016-8

[10]
Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.

Drug Dev Ind Pharm. 2016-1

引用本文的文献

[1]
Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise.

Front Pharmacol. 2018-9-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索